At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PODD Insulet
Pre-Mkt 02-25 06:06:13 EST
245.25
-4.13
-1.66%
High250.79Low241.77Vol1.27M
Open247.35D1 Closing249.38Amplitude3.62%
Mkt Cap17.25BTradable Cap17.19BTotal Shares70.35M
T/O312.64MT/O Rate1.82%Tradable Shares70.08M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Insulet Files Amended 8-K on Auditor Change Disclosure
Reuters  ·  06:25
Insulet Files Amended 8-K on Auditor Change Disclosure
Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates
Simply Wall St.  ·  01:21
Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates
Insulet Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
Dow Jones  ·  02-24 06:12
Insulet Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
Insulet Corp CEO Ashley Mcevoy Reports Open Market Purchase of 4,300 Co's Common Shares on Feb 20 at Avg Price $239.35/Share - SEC Filing
THOMSON REUTERS  ·  02-23 21:20
Insulet Corp CEO Ashley Mcevoy Reports Open Market Purchase of 4,300 Co's Common Shares on Feb 20 at Avg Price $239.35/Share - SEC Filing
Insulet President and CEO Ashley McEvoy Acquires Common Shares
Reuters  ·  02-23 21:15
Insulet President and CEO Ashley McEvoy Acquires Common Shares
Insulet Earnings Call Highlights Growth And Expansion
TIPRANKS  ·  02-22
Insulet Earnings Call Highlights Growth And Expansion
Insulet (PODD) Gets a Buy from BTIG
TIPRANKS  ·  02-21
Insulet (PODD) Gets a Buy from BTIG
Insulet Corp. Stock Underperforms Thursday When Compared To Competitors
Dow Jones  ·  02-20
Insulet Corp. Stock Underperforms Thursday When Compared To Competitors
Insulet Is Maintained at Buy by Citigroup
Dow Jones  ·  02-20
Insulet Is Maintained at Buy by Citigroup
Insulet Is Maintained at Overweight by JP Morgan
Dow Jones  ·  02-20
Insulet Is Maintained at Overweight by JP Morgan
Stock Track | Insulet Plummets 5.06% Intraday as Analysts Slash Price Targets After Q4 Results
Stock Track  ·  02-20
Stock Track | Insulet Plummets 5.06% Intraday as Analysts Slash Price Targets After Q4 Results
Truist Adjusts Price Target on Insulet to $360 From $390, Maintains Buy Rating
MT Newswires Live  ·  02-19
Truist Adjusts Price Target on Insulet to $360 From $390, Maintains Buy Rating
Truist Financial Sticks to Their Buy Rating for Insulet (PODD)
TIPRANKS  ·  02-19
Truist Financial Sticks to Their Buy Rating for Insulet (PODD)
Goldman Sachs Sticks to Its Buy Rating for Insulet (PODD)
TIPRANKS  ·  02-19
Goldman Sachs Sticks to Its Buy Rating for Insulet (PODD)
Insulet price target lowered to $340 from $380 at Citi
TIPRANKS  ·  02-19
Insulet price target lowered to $340 from $380 at Citi
Insulet price target raised to $286 from $274 at Barclays
TIPRANKS  ·  02-19
Insulet price target raised to $286 from $274 at Barclays
Insulet Corp : Leerink Partners Cuts Target Price to $360 From $386
THOMSON REUTERS  ·  02-19
Insulet Corp : Leerink Partners Cuts Target Price to $360 From $386
Insulet: Strong Q4 Execution and Encouraging 2026 Outlook Offset by Valuation and Competitive Pressures, Justifying Hold Rating
TIPRANKS  ·  02-19
Insulet: Strong Q4 Execution and Encouraging 2026 Outlook Offset by Valuation and Competitive Pressures, Justifying Hold Rating
Insulet: Sustained Growth Runway and Underappreciated Long‑Term Upside Support Buy Rating
TIPRANKS  ·  02-19
Insulet: Sustained Growth Runway and Underappreciated Long‑Term Upside Support Buy Rating
Insulet Price Target Maintained With a $380.00/Share by BTIG
Dow Jones  ·  02-19
Insulet Price Target Maintained With a $380.00/Share by BTIG

Introduction

Company Name.
Insulet
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Issue price:
--